CERAMAX CERAMIC HIP SYSTEM
Depuy Orthopaedics, Inc. · Decision date Aug 1, 2025
What did the FDA decide?
FDA records P070026/S122 as a supplement to PMA P070026, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 1, 2025.
FDA approval order statement
to reduce the inspection tier for the sponsors suppliers that have demonstrated successful quality history through the receiving inspection at the Cork facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Aug 1, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P070026/S122
- Regulatory pathway
- PMA supplement
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- MRA
- Decision code
- OK30
- Decision date
- Aug 1, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented.
- Applicant
- Depuy Orthopaedics, Inc.
- Product code
- MRA
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P070026. Subsequent supplements may change the device or its indications.
FDA decision timeline
P070026 · Original PMA
CERAMAX CERAMIC HIP SYSTEM
P070026/S122 received
Application receipt date recorded by FDA.
P070026/S122 · FDA decision
30-Day Notice
P070026/S121 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
P070026/S123 · Related supplement
Ceramax Ceramic Hip System
P070026/S118 · Related supplement
Ceramax Ceramic Total Hip System
P070026/S124 · Related supplement
Ceramax Ceramic Hip System
P070026/S125 · Related supplement
Ceramax Ceramic Hip System
P070026/S127 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
P070026/S128 · Related supplement
CERAMAX Ceramic Total Hip System
P070026/S130 · Related supplement
CERAMAX Ceramic Hip System
P070026/S129 · Related supplement
CERAMAX CERAMIC HIP SYSTEM
Timeline entries are records held by MedtechLedger for P070026. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P070026
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CERAMAX CERAMIC HIP SYSTEMP070026 | Depuy Orthopaedics, Inc. | PMA approval | Dec 23, 2010 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S121 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 5, 2025 | FDA |
Ceramax Ceramic Hip SystemP070026/S123 | Depuy Orthopaedics, Inc. | PMA supplement | Dec 9, 2025 | FDA |
Ceramax Ceramic Total Hip SystemP070026/S118 | Depuy Orthopaedics, Inc. | PMA supplement | Jan 8, 2026 | FDA |
Ceramax Ceramic Hip SystemP070026/S124 | Depuy Orthopaedics, Inc. | PMA supplement | Apr 10, 2026 | FDA |
Ceramax Ceramic Hip SystemP070026/S125 | Depuy Orthopaedics, Inc. | PMA supplement | Apr 29, 2026 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S127 | Depuy Orthopaedics, Inc. | PMA supplement | Jun 3, 2026 | FDA |
CERAMAX Ceramic Total Hip SystemP070026/S128 | Depuy Orthopaedics, Inc. | PMA supplement | Jul 24, 2026 | FDA |
CERAMAX Ceramic Hip SystemP070026/S130 | Depuy Orthopaedics, Inc. | PMA supplement | Aug 27, 2026 | FDA |
CERAMAX CERAMIC HIP SYSTEMP070026/S129 | Depuy Orthopaedics, Inc. | PMA supplement | Sep 4, 2026 | FDA |
Explore the linked device profile
Other records with product code MRA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| HOWMEDICA OSTEONICS CORP | PMA supplement | Sep 17, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Depuy Orthopaedics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 700 Orthopaedic Dr., Warsaw, IN, 46582
Sources and methodology
- Original FDA record: P070026/S122
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




